Opella and Long Chau take care of digestive and joint health for the community

Vinh Phú |

On February 4th, Opella Vietnam in coordination with the Long Chau pharmacy system and vaccination center launched the project "Taking care of digestive and joint health for the community".

Opella and Long Chau Pharmaceutical and Vaccination Center System have signed a Memorandum of Understanding on cooperation, establishing a long-term strategic cooperation relationship.

The two sides launched the project with many practical initiatives, including programs to improve the capacity of pharmacists, community health care activities such as bone density measurement, health consultation, and education programs for people, to be implemented in 2026.

The cooperation between Opella and Long Chau demonstrates a sustainable approach, focusing on science and people, towards improving the quality of community healthcare.

According to the cooperation agreement, Opella will accompany Long Chau in building a roadmap to improve capacity for the team of pharmacy pharmacists, focusing on areas such as pathological knowledge, pharmacological risk management and patient counseling skills.

Opella also supports connecting lecturers, providing medical knowledge and coordinating the organization of training programs through online courses, professional seminars, etc.

Opella and Long Chau coordinate to implement community awareness campaigns through digital platforms, pharmacy systems,...

Vinh Phú
TIN LIÊN QUAN

Opella achieves global B Corp certification

|

On June 26, Opella was the first consumer healthcare company globally to achieve B Corp certification, after meeting strict social and environmental standards set by the nonprofit organization B Lab. This certification marks an important milestone in Opella's journey to provide responsible self-care solutions for people and the planet.

Opella officially becomes an independent enterprise

|

On May 8, Opella officially became an independent enterprise, right after Sanofi announced the completion of the transaction of transferring 50% of controlled shares in Opella to CD&R Investment Fund. Sanofi still retains a significant stake of 48.2% and the remaining 1.8% is owned by French public investment bank Bpifrance. With strong support from all sides, Opella will enter the next stage of development with the mission of "Health is within reach, through self-care".

Opella và Nhà thuốc An Khang hợp tác chiến lược vì sức khỏe cộng đồng

Vinh Phú |

Ngày 5.9, Opella và Nhà thuốc An Khang ký kết biên bản ghi nhớ thiết lập quan hệ đối tác chiến lược, mở đầu cho các chương trình hợp tác nâng cao sức khỏe cộng đồng trong một năm tới. Thông qua các hoạt động đồng hành, hai bên cùng hướng đến mục tiêu: "Cam kết sản phẩm chất lượng, an toàn và minh bạch nguồn gốc - Đồng hành cùng sức khỏe người Việt". Theo thỏa thuận chung, Opella và Nhà thuốc An Khang đảm bảo cung ứng các sản phẩm chính hãng được kiểm định rõ ràng ra thị trường, góp phần chống hàng giả,...

Opella achieves global B Corp certification

Vinh Phú |

On June 26, Opella was the first consumer healthcare company globally to achieve B Corp certification, after meeting strict social and environmental standards set by the nonprofit organization B Lab. This certification marks an important milestone in Opella's journey to provide responsible self-care solutions for people and the planet.

Opella officially becomes an independent enterprise

Vinh Phú |

On May 8, Opella officially became an independent enterprise, right after Sanofi announced the completion of the transaction of transferring 50% of controlled shares in Opella to CD&R Investment Fund. Sanofi still retains a significant stake of 48.2% and the remaining 1.8% is owned by French public investment bank Bpifrance. With strong support from all sides, Opella will enter the next stage of development with the mission of "Health is within reach, through self-care".